Hereditary palmoplantar keratoderma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79357
Who is this for?
Show terms as
1Active trials8Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2024Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

Indiana University — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Hereditary palmoplantar keratoderma.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
Phase 2
Actively Recruiting
PI: David Rosmarin, MD (Dermatology) · Sites: Indianapolis, Indiana · Age: 1899 yrs

Specialists

8 foundView all specialists →
AP
Antoni Gostynski, MD, PhD
Maastricht, Limburg
Specialist

Rare Disease Specialist

PI on 2 active trials
CB
Christine BODEMER
Bobigny
Specialist

Rare Disease Specialist

PI on 2 active trials
JP
Johanna H Hagman, M.D, PhD
Specialist
PI on 1 active trial
SP
Simon W Young, DDS, MD, PhD
Specialist
PI on 1 active trial
KM
Konika P Schallen, MD
JACKSONVILLE, FL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary palmoplantar keratoderma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary palmoplantar keratodermaForum →

No community posts yet. Be the first to share your experience with Hereditary palmoplantar keratoderma.

Start the conversation →

Latest news about Hereditary palmoplantar keratoderma

Disease timeline:

New recruiting trial: Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

A new clinical trial is recruiting patients for Hereditary palmoplantar keratoderma

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary palmoplantar keratoderma

Are there clinical trials for Hereditary palmoplantar keratoderma?

Yes — 1 recruiting clinical trial is currently listed for Hereditary palmoplantar keratoderma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Hereditary palmoplantar keratoderma?

8 specialists and care centers treating Hereditary palmoplantar keratoderma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.